Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income
07:05am, Wednesday, 17'th Jul 2024
If you are a passive income investor like me, you will always be on the lookout for high-yield dividend stocks. However, not all stocks are made equal.
Johnson & Johnson stock gets a lift from earnings beat, while outlook was mixed
06:34am, Wednesday, 17'th Jul 2024
Shares of Johnson & Johnson JNJ, +1.19% rose 1.1% in premarket trading Wednesday, after the drug maker beat second-quarter profit and sales expectations, while providing a mixed full-year outlook. Net
J&J beats Wall Street estimates on strong drug sales
06:22am, Wednesday, 17'th Jul 2024
Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara.
Johnson & Johnson Earnings Are Coming. It Took Steps to Put Its Talc Issues Behind It.
04:00pm, Tuesday, 16'th Jul 2024
ohnson & Johnson is expected to report earnings of $2.71 a share, down slightly from $2.80 from the same period a year ago.
3 Safe Dividend Kings to Recession-Proof Your Portfolio
03:04pm, Tuesday, 16'th Jul 2024
Income investors should focus on stocks that pay solid yields, but also those that have sustainable payouts and strong business models. Dividend kings are an excellent place to look for stocks with su
Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings
12:46pm, Tuesday, 16'th Jul 2024
Johnson & Johnson JNJ is reporting its second-quarter earnings on Wednesday. Wall Street expects $2.7 in EPS and $22.3 billion in revenues as the company reports before market hours.
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
08:06am, Tuesday, 16'th Jul 2024
Johnson & Johnson JNJ will release its second-quarter financial results, before the opening bell on Wednesday, July 17.
MedTech To Drive Johnson & Johnson's Q2?
07:00am, Tuesday, 16'th Jul 2024
Johnson & Johnson stock (NYSE: JNJ) will report its Q2 2024 results on Wednesday, July 17. We expect the company to post revenue of $22.5 billion and earnings of $2.72 per share, broadly aligning with
If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names
06:15am, Tuesday, 16'th Jul 2024
Finding Dow stocks to buy is often seen as a conservative yet effective strategy for those looking to secure stable returns with minimal risk. The Dow Jones Industrial Average comprises companies from
J&J (JNJ) Stock Before Q2 Earnings: To Buy or Not to Buy?
11:50am, Monday, 15'th Jul 2024
J&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. Surgical procedure recovery and new products are likely to have driven MedTech sales.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
06:38am, Monday, 15'th Jul 2024
Litigation concerns have pushed Johnson & Johnson to an appealing price. Dividend investors will love AbbVie's high yield and resilient growth.
2 Healthcare Stocks to Buy Hand Over Fist This Month
09:31am, Sunday, 14'th Jul 2024
Johnson & Johnson and Medtronic are healthcare leaders that have faced their share of issues in recent years. Still, both companies have the innovative capabilities and expertise to succeed in the ind
3 High-Yield Dividend Stocks That Still Look Like Bargains
04:27am, Sunday, 14'th Jul 2024
Johnson & Johnson and AbbVie produce reliable earnings driven by sales of patent-protected drugs. Real estate investment trust Agree Realty makes monthly dividend payments.
3 Key Earnings Reports to Watch Next Week
08:15pm, Friday, 12'th Jul 2024
With the 2024 Q2 earnings season kicking into a much higher gear next week, there are several reports investors should keep on their radars, including these three.
Three-Stock Lunch: JPMorgan, Johnson & Johnson and On Holding
03:52pm, Friday, 12'th Jul 2024
Quint Tatro, Joule Financial founder and president, joins 'Power Lunch' to discuss stock plays for three stocks.
